Endocrine and metabolic diseases. Adrenal diseases.
作者信息
Besser G M, Jeffcoate W J
出版信息
Br Med J. 1976 Feb 21;1(6007):448-51. doi: 10.1136/bmj.1.6007.448.
Abstract
摘要
相似文献
1
Endocrine and metabolic diseases. Adrenal diseases.内分泌与代谢疾病。肾上腺疾病。
Br Med J. 1976 Feb 21;1(6007):448-51. doi: 10.1136/bmj.1.6007.448.
2
Clinical therapeutics of adrenal disorders.
Am J Med. 1972 Nov;53(5):673-84. doi: 10.1016/0002-9343(72)90162-3.
3
Medical management of adrenal disease: a narrative review.
Endocr Regul. 2009 Jul;43(3):127-35.
4
Adrenal carcinoma.肾上腺皮质癌
Curr Ther Endocrinol Metab. 1994;5:155-7.
5
Adrenal causes of hypertension.高血压的肾上腺病因。
Arch Intern Med. 1974 Jun;133(6):1001-6.
6
Proceedings: Tumors of the adrenal cortex.
Cancer. 1973 Nov;32(5):1227-35. doi: 10.1002/1097-0142(197311)32:5<1227::aid-cncr2820320532>3.0.co;2-m.
7
Postoperative course and treatment in adrenal surgery. II. Cushing's syndrome and pheochromocytoma.
Urol Int. 1971;26(1):13-23. doi: 10.1159/000279709.
8
[Corticosteroidogenesis inhibitors. II. A new cortico-adrenal inhibitor: amino-glutethimide (16,038Ba)].[皮质类固醇生成抑制剂。II. 一种新的肾上腺皮质抑制剂：氨基谷氨酰胺（16,038Ba）]
Presse Med (1893). 1968 May 11;76(23):1107-10.
9
Cushing's syndrome due to bilateral adrenal cortical hyperplasia in a 13-year old girl: successful treatment with op'DDD'.
Helv Paediatr Acta. 1974 Aug;29(3):195-202.
10
[Cushing's syndrome. Medical treatment of adrenal hypercorticism].[库欣综合征。肾上腺皮质功能亢进的医学治疗]
Horm Res. 1980;13(4-5):317-24. doi: 10.1159/000179298.
引用本文的文献
1
Cardiovascular risk and glucocorticoids: a Dutch National Registry of growth hormone treatment in adults with growth hormone deficiency analysis.心血管风险与糖皮质激素：荷兰成人生长激素缺乏症患者生长激素治疗注册研究分析。
Pituitary. 2024 Oct;27(5):590-604. doi: 10.1007/s11102-024-01448-2. Epub 2024 Aug 31.
2
Significant barriers to diagnosis and management of adrenal insufficiency in Africa.非洲肾上腺功能不全诊断与管理面临的重大障碍。
Endocr Connect. 2020 May;9(5):445-456. doi: 10.1530/EC-20-0129.
3
Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion.针对肾上腺功能不全的糖皮质激素替代治疗的调整：意大利内分泌学会专家意见。
J Endocrinol Invest. 2020 May;43(5):683-696. doi: 10.1007/s40618-019-01146-y. Epub 2019 Nov 26.
4
Dual-release Hydrocortisone in Addison's Disease - A Review of the Literature.艾迪生病中的双相释放氢化可的松——文献综述
Eur Endocrinol. 2014 Feb;10(1):75-78. doi: 10.17925/EE.2014.10.01.75. Epub 2014 Feb 28.
5
Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison's disease.采用双释放氢化可的松治疗艾迪生病患者后人体测量学和代谢参数及生活质量的改善情况。
Endocrine. 2016 Feb;51(2):360-8. doi: 10.1007/s12020-015-0681-z. Epub 2015 Jul 17.
6
Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers.正常志愿者在接受生理剂量和应激剂量氢化可的松后血浆、唾液及尿液中的皮质醇水平
BMC Endocr Disord. 2014 Nov 26;14:91. doi: 10.1186/1472-6823-14-91.
7
Glucocorticoid effects on adiponectin expression.糖皮质激素对脂联素表达的影响。
Vitam Horm. 2012;90:163-86. doi: 10.1016/B978-0-12-398313-8.00007-5.
8
Pharmacokinetic evidence for suboptimal treatment of adrenal insufficiency with currently available hydrocortisone tablets.目前市售氢化可的松片剂治疗肾上腺功能不全疗效欠佳的药代动力学证据。
Clin Pharmacokinet. 2010 Jul;49(7):455-63. doi: 10.2165/11531290-000000000-00000.
9
Metabolic and cardiovascular profile in patients with Addison's disease under conventional glucocorticoid replacement.艾迪生病患者在接受常规糖皮质激素替代治疗下的代谢和心血管特征。
J Endocrinol Invest. 2009 Dec;32(11):917-23. doi: 10.1007/BF03345773. Epub 2009 Jul 20.
10
Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study.纠正皮质醇替代过量可改善垂体功能减退患者的并发症：一项试点研究。
Pituitary. 2008;11(3):279-85. doi: 10.1007/s11102-008-0126-2.
Zotero 插件